184 related articles for article (PubMed ID: 26731699)
1. Long-Term Follow-Up of a Homozygous Familial Hypercholesterolemic Patient Receiving Regular Double Filtration Plasmapheresis - Case Report and Literature Review.
Tsai JL; Wu MJ; Shu KH; Tsai SF
Blood Purif; 2016; 41(4):264-9. PubMed ID: 26731699
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
Fernández-Fuertes LF; Tapia Martín M; Nieves Plá I; Novoa Mogollón FJ; Díaz Cremades J
Ther Apher Dial; 2010 Oct; 14(5):484-5. PubMed ID: 21175548
[No Abstract] [Full Text] [Related]
3. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ;
Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658
[TBL] [Abstract][Full Text] [Related]
4. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).
Kayikcioglu M; Tokgozoglu L; Yilmaz M; Kaynar L; Aktan M; Durmuş RB; Gokce C; Temizhan A; Ozcebe OI; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Yenercag M; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O
Atherosclerosis; 2018 Mar; 270():42-48. PubMed ID: 29407887
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia.
Thiery J; Walli AK; Janning G; Seidel D
Eur J Pediatr; 1990 Jul; 149(10):716-21. PubMed ID: 2209665
[TBL] [Abstract][Full Text] [Related]
6. Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis.
Galiano M; Hammersen J; Sauerstein K; Blessing H; Rümmele P; Purbojo A; Schöber M; Moosmann J; Raffelsbauer G; Heibges A; Klingel R
J Clin Apher; 2020 Jun; 35(3):163-171. PubMed ID: 32163632
[TBL] [Abstract][Full Text] [Related]
7. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.
Stein EA; Dann EJ; Wiegman A; Skovby F; Gaudet D; Sokal E; Charng MJ; Mohamed M; Luirink I; Raichlen JS; Sundén M; Carlsson SC; Raal FJ; Kastelein JJP
J Am Coll Cardiol; 2017 Aug; 70(9):1162-1170. PubMed ID: 28838366
[TBL] [Abstract][Full Text] [Related]
9. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
10. Apheresis technology for prevention and regression of atherosclerosis.
Yamamoto A; Harada-Shiba M; Kawaguchi A; Tsushima M
Ther Apher; 2001 Aug; 5(4):221-5. PubMed ID: 11724504
[TBL] [Abstract][Full Text] [Related]
11. Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis.
Dann EJ; Shamir R; Mashiach T; Shaoul R; Badian A; Stravets T; Kerzman Y; Finkelbaum S; Gaitini D; Lorber A; Bonstein L
Transfus Apher Sci; 2013 Oct; 49(2):268-77. PubMed ID: 23791799
[TBL] [Abstract][Full Text] [Related]
12. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry.
Luirink IK; Hutten BA; Greber-Platzer S; Kolovou GD; Dann EJ; de Ferranti SD; Taylan C; Bruckert E; Saheb S; Oh J; Driemeyer J; Farnier M; Pape L; Schmitt CP; Novoa FJ; Maeser M; Masana L; Shahrani A; Wiegman A; Groothoff JW
Atherosclerosis; 2020 Apr; 299():24-31. PubMed ID: 32199148
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study.
Scheel AK; Schettler V; Koziolek M; Koelling S; Werner C; Müller GA; Strutz F
Atherosclerosis; 2004 May; 174(1):133-9. PubMed ID: 15135262
[TBL] [Abstract][Full Text] [Related]
14. Effects of Liver Transplantation on Lipids and Cardiovascular Disease in Children With Homozygous Familial Hypercholesterolemia.
Martinez M; Brodlie S; Griesemer A; Kato T; Harren P; Gordon B; Parker T; Levine D; Tyberg T; Starc T; Cho I; Min J; Elmore K; Lobritto S; Hudgins LC
Am J Cardiol; 2016 Aug; 118(4):504-10. PubMed ID: 27365335
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A
Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047
[TBL] [Abstract][Full Text] [Related]
16. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experience.
Albayrak M; Yıldız A; Ateş N; Pala Ç
Transfus Apher Sci; 2019 Feb; 58(1):61-64. PubMed ID: 30545658
[TBL] [Abstract][Full Text] [Related]
18. Familial homozygous hypercholesterolemia: effective long-term treatment with cascade double filtration plasmapheresis.
Demetriou K; H'Maltezou E; Pierides AM
Blood Purif; 2001; 19(3):308-13. PubMed ID: 11244191
[TBL] [Abstract][Full Text] [Related]
19. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
Tsuchida M; Kawashiri MA; Tada H; Takata M; Nohara A; Ino H; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M
Circ J; 2009 May; 73(5):963-6. PubMed ID: 19088396
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review.
Luirink IK; Determeijer J; Hutten BA; Wiegman A; Bruckert E; Schmitt CP; Groothoff JW
J Clin Lipidol; 2019; 13(1):31-39. PubMed ID: 30553758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
